Glanbia PLC (GL9.IR) stock: key figures, P/E, revenue and dividend

Consumer Staples · Ireland · ISIN IE0000669501

Price
23.01 EUR
Market cap
4.97 bn EUR
P/E (2025)
27.11
P/S (2025)
1.26
Dividend yield
2.18 %
Net margin
4.64 %
Return on equity (ROE)
9.51 %
Return on assets (ROA)
4.61 %

Glanbia PLC financials

Fiscal year20242025
Revenue3.84 bn USD3.95 bn USD
Gross profit1.17 bn USD1.06 bn USD
Operating income–274.10 m USD
EBIT395.00 m USD–
Net income164.00 m USD183.30 m USD
Diluted EPS – continuing operations0.62 USD–

Full history since 1985, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Glanbia PLC

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services and management solutions; and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, think!, Amazing Grass brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 21.10.2026. Details in the risk notice.

Glanbia PLC stock (GL9.IR): P/E, revenue, dividend | finmetric